Saskatoon-based MustGrow Biologics (MustGrow Biologics Inventory Quote, Chart, Information, Analysts, Financials TSXV:MGRO) is bringing biotechnology and regenerative agriculture collectively to assist farmers change artificial chemical compounds and fertilizers, CEO Corey Giasson mentioned in an Oct. 31 interview on the Cantech Letter YouTube channel.
Talking with Ticker Take host Jon Erlichman on the 2025 Cantech Funding Convention in Toronto, Giasson mentioned the corporate’s patented mustard-seed know-how is now transferring from analysis to full business manufacturing.
“MustGrow is an agricultural biotech firm,” Giasson mentioned. “We’ve received a patented know-how round mustard that extracts compounds from mustard seed, reformulates them into biopesticides and biofertility merchandise to assist change artificial chemical compounds or fertilizers and assist regenerative agriculture.”
He mentioned the method attracts on nature’s personal defences. “You eat it when you will have mustard, it’s the spice that you simply get inside the mustard, and it simply so occurs that it’s very efficient at treating ailments and pests that farmers must be involved about,” he mentioned. “It’s the pure defence mechanism of that plant.”
MUSTGROW BIOLOGICS CEO COREY GIASSON SITS DOWN WITH JON ERLICHMAN AT THE 2025 CANTECH INVESTMENT CONFERENCE
Giasson added that regulatory and client pressures are accelerating the shift towards biologic alternate options.
“We’re seeing vital progress,” he mentioned. “We’ve seen fairly a little bit of pesticides or chemical compounds being banned or restricted, and farmers nonetheless need to develop crops with a finite quantity of arable land. That’s what we’re bringing to the desk, a pure biologic that works.”
MustGrow has additionally broadened its attain with the acquisition of NexusBioAg, a Canadian gross sales and distribution enterprise centered on regenerative agriculture merchandise.
“So we’re a completely built-in agriculture supplier,” Giasson mentioned.
He mentioned the corporate has lately entered a brand new section.
“I’m excited that we’ve turned the nook and we’re now in commercialization and gross sales,” Giasson mentioned. “We’ve performed about $6.6-million of income within the first half of this 12 months, and we need to proceed to drive that quantity via NexusBioAg in Canada and thru TerraSante, our biofertility product registered in the USA.”
TerraSante is a wettable-powder soil additive derived from mustard seed, used to enhance soil well being, water capability, and plant efficiency. Giasson mentioned early demand has exceeded expectations.
“We ran out of product this spring; it’s a great drawback to have, nevertheless it’s an issue,” he mentioned. “We’re now seeking to ramp up manufacturing in order that we will meet demand subsequent 12 months. The sphere trials have proven constructive outcomes, and we’re beginning to see repeat gross sales.”
-30-
Loading extra…
Elevate your perspective with NextTech Information, the place innovation meets perception.
Uncover the newest breakthroughs, get unique updates, and join with a world community of future-focused thinkers.
Unlock tomorrow’s tendencies at this time: learn extra, subscribe to our publication, and develop into a part of the NextTech group at NextTech-news.com
